🔗 Permalink

Inventor profile of:

Michael OHLMEYER

City:

Plainsboro, New Jersey

Country:

United States

Published Applications:

Last publication date:

2026-03-05

Top Assignees for applications by Michael OHLMEYER

The entities that hold a legal rights for patent applications filed by inventor OHLMEYER Michael:

Icahn School of Medicine at Mount Sinai 11 New York, NY United States
N.V. Organon 5 Oss, Netherlands
Atux Iskay LLC 2 Plainsboro, NJ United States
PHARMACOPEIA, LLC 2 San Diego, CA United States
PHARMACOPEIA, INC. 2 Cranbury, NJ United States
MSD Oss B.V. 2 Oss, Netherlands
Wyeth LLC 1 Madison, NJ United States
OTSUKA PHARMACEUTICAL FACTORY, INC. 1 Tokushima, Japan
Merck Sharp & Dohme B.V. 1 Oss, Netherlands
Pharmacopeia Drug Discovery, Inc. 1 Cranbury, NJ United States
Pharmacopeia Drug Discovery, Inc. 1 Princeton, NJ United States
N.V. ORGANON AND PHARMACOPEIA, LLC 1 Oss, Netherlands
Mount Sinai School of Medicine 1 New York, NY United States
OTSUKA PHARMACEUTICAL FACTORY, INC. 1 Naruto-shi, Japan
MT. SINAI SCHOOL OF MEDICINE 1 New York, NY United States
Ichan School of Medicine at Mount Sinai 1 New York, NY United States
OTSUKA PHARMACEUTICAL FACTORY, INC. 1 Naruto-shi, Tokushima, Japan

Recent patent applications by OHLMEYER Michael

Michael OHLMEYER from Plainsboro, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-05

US20260062397A1

Chemistry; metallurgy

2-DIARYLMETHYL-4-AMINOTETRAHYDROPYRAN DERIVATIVES AND RELATED COMPOUNDS AS ANTICANCER, ANTIINFLAMMATORY, ANTIFIBROTIC AND NEUROPROTECTIVE AGENTS

#2 | 2025-12-18

US20250382270A1

Chemistry; metallurgy

3-DIARYLMETHYLENES AND USES THEREOF

#3 | 2025-12-11

US20250376455A1

Chemistry; metallurgy

2-DIARYLMETHYL-4-AMINOTETRAHYDROPYRAN DERIVATIVES AND RELATED COMPOUNDS AS ANTICANCER, ANTIINFLAMMATORY, ANTIFIBROTIC AND NEUROPROTECTIVE AGENTS

#4 | 2025-11-06

US20250340514A1

Chemistry; metallurgy

3-DIARYLMETHYLENES AND USES THEREOF

#5 | 2024-11-07

US20240368105A1

Chemistry; metallurgy

2-DIARYLMETHYL-4-AMINOTETRAHYDROPYRAN DERIVATIVES AND RELATED COMPOUNDS AS ANTICANCER, ANTIINFLAMMATORY, ANTIFIBROTIC AND NEUROPROTECTIVE AGENTS

#6 | 2023-05-11

US20230146127A1

Chemistry; metallurgy

3-DIARYLMETHYLENES AND USES THEREOF

#7 | 2018-09-06

US20180251456A1

Chemistry; metallurgy

Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents

#8 | 2018-09-06

US20180251444A1

Chemistry; metallurgy

Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents

#9 | 2018-08-16

US20180230112A1

Chemistry; metallurgy

Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols

#10 | 2018-04-19

US20180105485A1

Chemistry; metallurgy

Cyclic vinylogous amides as bromodomain inhibitors

#11 | 2018-01-04

US20180002339A1

Chemistry; metallurgy

TRICYCLIC HETEROCYCLES AS ANTICANCER AGENTS

#12 | 2017-01-19

US20170015630A1

Chemistry; metallurgy

Constrained tricyclic sulfonamides

#13 | 2017-01-19

US20170015625A1

Chemistry; metallurgy

Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents

#14 | 2016-07-14

US20160200666A1

Chemistry; metallurgy

Cyclic vinylogous amides as bromodomain inhibitors

#15 | 2015-12-31

US20150376191A1

Chemistry; metallurgy

Tricyclic heterocycles as anticancer agents

#16 | 2015-08-13

US20150224101A1

Human necessities

Method and compositions for treating cancer and related methods

#17 | 2014-07-31

US20140213578A1

Chemistry; metallurgy

Tricyclic compounds as anticancer agents

#18 | 2014-03-06

US20140066410A1

Chemistry; metallurgy

INHIBITORS OF BROMODOMAINS AS MODULATORS OF GENE EXPRESSION

#19 | 2013-11-07

US20130296342A1

Human necessities

Lipoprotein lipase-activating compositions comprising benzene derivates

#20 | 2012-12-20

US20120322792A1

Physics

Method and compositions for treating cancer and related methods

#21 | 2012-01-19

US20120015958A1

Chemistry; metallurgy

1-(4-ureidobenzoyl)piperazine derivatives

#22 | 2011-09-08

US20110218189A1

Chemistry; metallurgy

PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS

#23 | 2011-03-17

US20110065764A1

Chemistry; metallurgy

5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators

#24 | 2011-03-17

US20110065728A1

Human necessities

LIPOPROTEIN LIPASE-ACTIVATING COMPOSITIONS COMPRISING BENZENE DERIVATIVES

#25 | 2011-02-24

US20110046131A1

Chemistry; metallurgy

PURINES AS PKC-THETA INHIBITORS

#26 | 2009-10-22

US20090264416A1

Chemistry; metallurgy

N-benzyl,N'-arylcarbonylpiperazine derivatives

#27 | 2008-09-04

US20080214553A1

Chemistry; metallurgy

2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists

#28 | 2008-04-17

US20080090802A1

Chemistry; metallurgy

Quinazolinone and isoquinolinone acetamide derivatives

#29 | 2008-04-10

US20080085909A1

Chemistry; metallurgy

Purinones and 1H-imidazopyridinones as PKC-theta inhibitors

#30 | 2008-04-10

US20080085898A1

Chemistry; metallurgy

8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression

#31 | 2008-03-13

US20080064678A1

Chemistry; metallurgy

2-(1-oxo-1-isoquinolin-2-yl)acetamide derivatives

#32 | 2007-06-28

US20070149577A1

Chemistry; metallurgy

Compounds with medicinal effects due to interaction with the glucocorticoid receptor

InventorID:

520018 ⎘